96 related articles for article (PubMed ID: 11355925)
81. Emerging treatments in acute myeloid leukaemia.
Kell J
Expert Opin Emerg Drugs; 2004 May; 9(1):55-71. PubMed ID: 15155136
[TBL] [Abstract][Full Text] [Related]
82. Acute myeloid leukaemia (AML): treatment of the older patient.
Büchner T; Hiddemann W; Schoch C; Haferlach T; Sauerland MC; Heinecke A
Best Pract Res Clin Haematol; 2001 Mar; 14(1):139-51. PubMed ID: 11355928
[TBL] [Abstract][Full Text] [Related]
83. Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers.
Löfström B; Backlin C; Sundström C; Hellström-Lindberg E; Ekbom A; Lundberg IE
Rheumatology (Oxford); 2009 Oct; 48(10):1222-6. PubMed ID: 19608725
[TBL] [Abstract][Full Text] [Related]
84. Current therapeutic strategies for acute myeloid leukaemia.
Kolitz JE
Br J Haematol; 2006 Sep; 134(6):555-72. PubMed ID: 16848792
[TBL] [Abstract][Full Text] [Related]
85. Biology and management of relapsed acute myeloid leukaemia.
Craddock C; Tauro S; Moss P; Grimwade D
Br J Haematol; 2005 Apr; 129(1):18-34. PubMed ID: 15801952
[TBL] [Abstract][Full Text] [Related]
86. Advances in understanding the mechanisms and management of acute myelogenous leukemia.
Yeager KA; Miaskowski C
Oncol Nurs Forum; 1994 Apr; 21(3):541-8. PubMed ID: 8052550
[TBL] [Abstract][Full Text] [Related]
87. Prognostic factors in acute myeloid leukaemia.
Löwenberg B
Best Pract Res Clin Haematol; 2001 Mar; 14(1):65-75. PubMed ID: 11355924
[TBL] [Abstract][Full Text] [Related]
88. Acute myeloid leukaemia.
Stevens RF
Br Med Bull; 1996 Oct; 52(4):764-77. PubMed ID: 9039730
[TBL] [Abstract][Full Text] [Related]
89. Therapy-related leukemia associated with alkylating agents.
Davies SM
Med Pediatr Oncol; 2001 May; 36(5):536-40. PubMed ID: 11340608
[TBL] [Abstract][Full Text] [Related]
90. Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
Meshinchi S; Smith FO; Arceci RJ
Curr Oncol Rep; 2003 Nov; 5(6):489-97. PubMed ID: 14521808
[TBL] [Abstract][Full Text] [Related]
91. Guidelines on the management of acute myeloid leukaemia in adults.
; Milligan DW; Grimwade D; Cullis JO; Bond L; Swirsky D; Craddock C; Kell J; Homewood J; Campbell K; McGinley S; Wheatley K; Jackson G
Br J Haematol; 2006 Nov; 135(4):450-74. PubMed ID: 17054678
[No Abstract] [Full Text] [Related]
92. Acute myeloid leukaemia in children.
Langmuir PB; Aplenc R; Lange BJ
Best Pract Res Clin Haematol; 2001 Mar; 14(1):77-93. PubMed ID: 11355925
[TBL] [Abstract][Full Text] [Related]
93. Curing childhood acute myeloid leukemia (AML) at the half-way point: promises to keep and miles to go before we sleep.
Woods WG
Pediatr Blood Cancer; 2006 May; 46(5):565-9. PubMed ID: 16261562
[TBL] [Abstract][Full Text] [Related]
94. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
95. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
[TBL] [Abstract][Full Text] [Related]
96. Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia.
Zwaan CM; Kaspers GJ
Br J Haematol; 2004 Nov; 127(3):264-79. PubMed ID: 15491285
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
